CEPI, IVI and MRC Unit The Gambia to bolster clinical research capacity in West Africa to combat regional viral threat

The Coalition for Epidemic Preparedness Innovations (CEPI), the Republic of Korea-based International Vaccine Institute ...

November 30, 2023 | Thursday | News
Japanese firm Mitsui invests $8 M in US-based clinical intelligence startup Lokavant

US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...

October 10, 2023 | Tuesday | News
Buzzreach and Oncoshot spearhead clinical trial advancements in Japan

Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration ...

September 14, 2023 | Thursday | News
Australia shines in clinical trial activity ranking but gaps exist

An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as...

August 18, 2023 | Friday | News
Why India Is Most Preferred Clinical Trials Destination

According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...

July 4, 2023 | Tuesday | Opinion
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...

June 28, 2023 | Wednesday | Company results
Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial

Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...

May 30, 2023 | Tuesday | News
Singapore-based startup Hummingbird Bioscience inks oncology deal with Merck

Singapore-based startup Hummingbird Bioscience has entered into a clinical trial collaboration and supply agreement with...

May 17, 2023 | Wednesday | News
EBPs are leveraging digitalisation to drive innovation and improve patient outcomes

How do you define the essentials of a decentralised approach in the current drug discovery landscape? It is essential t...

May 5, 2023 | Friday | Opinion
Japan bags new opportunity to improve healthcare system

Omi Medical Center, a part of the Seikoukai Social Medical Corporation and one of Japan's leading institu...

February 27, 2023 | Monday | News
Groundbreaking trial underway for treatment of advanced Retinitis Pigmentosa in Australia

In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian Contract ...

February 15, 2023 | Wednesday | News
Ph I trial of first needle-free influenza vaccine begins in Australia

Australian biotech firm Vaxxas has announced the initiation of a Phase I clinical trial with the first inactivated ...

February 13, 2023 | Monday | News
Korea's Wellmarker Bio inks cancer drug trial collaboration with Merck

South Korean firm Wellmarker Bio (WMBIO) has entered a clinical trial collaboration and supply agreement with Merck (kno...

February 10, 2023 | Friday | News
CardieX & Invaryant enable clinical trials with advanced new AI medical technology

Australia's CardieX Limited, a global health technology company focused on patient-centric healthcare research and impro...

January 5, 2023 | Thursday | News
NZ-based P3 Research secures investment from Genesis Capital to accelerate expansion

P3 Research, a leading New Zealand (NZ) clinical trials site network with seven locations across New Zealand, has t...

December 23, 2022 | Friday | News
New Zealand's health agencies explore ways to improve clinical trials

New Zealand's leading health agencies will explore system-level changes to improve benefits from clinical trials, based ...

December 15, 2022 | Thursday | News
Oncoshot and Novotech partner to offer cancer data insights in APAC

Singapore-based startup Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun...

November 11, 2022 | Friday | News
Chinese startup Jacobio Pharma partners with Merck for cancer clinical trial

China-based startup Jacobio has entered into a clinical trial collaboration agreement with Merck on clinical study of co...

October 14, 2022 | Friday | News